IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Estrella Immunopharma Inc (ESLA)

CUSIP: 297584104 | NYSE | Healthcare · Biotechnology | Micro Cap | 34 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AArmistice Capital, LLC2,051,4095.0%Newly reportedJun 30, 2026No 13F filer matched
13G/AArmistice Capital, LLC2,051,409
5.0% of class · Jun 30, 2026

Institutional Holders — Q3 2026

Geode Capital Management, LLC141,138
0.0% of portfolio›$65.9K
Citigroup Inc5,910
0.0% of portfolio›$2.8K
Wolverine Asset Management LLC468
0.0% of portfolio›$218
Caitong International Asset Management Co., Ltd2
0.0% of portfolio›$1
Barclays PLC2
0.0% of portfolio›$1
StyleTurnoverLocationFiled
Geode Capital Management, LLC
141,138$65.9K0.0%IndexVery LowBoston, MA2026-11-06
Citigroup Inc
5,910$2.8K0.0%CoreMediumNew York, NY2026-11-04
Wolverine Asset Management LLC
468$2180.0%Deep ValueVery HighChicago, IL2026-11-02
Caitong International Asset Management Co., Ltd
2$10.0%GrowthVery HighHong Kong, South Korea2026-10-29
Barclays PLC
2$10.0%CoreMediumLondon, United Kingdom2026-11-06
Newly reported
No 13F filer matched